Regulon

Regulon: R-1927

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
142.2559613Pr-156Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
54677 ENSG00000005469 CROT Q9UKG9
26031 ENSG00000070882 OSBPL3 Q9H4L5
55972 ENSG00000075303 SLC25A40 Q8TBP6
64927 ENSG00000103852 TTC23 Q5W5X9
10564 ENSG00000124198 ARFGEF2 Q9Y6D5
10451 ENSG00000134215 VAV3 Q9UKW4
29969 ENSG00000135272 MDFIC C9J104
4547 ENSG00000138823 MTTP P55157
54970 ENSG00000149292 TTC12 Q9H892
10466 ENSG00000164597 COG5 U3KQU7
5028 ENSG00000169860 P2RY1 P47900
4299 ENSG00000172493 AFF1 P51825
50618 ENSG00000198399 ITSN2 Q9NZM3
54809 ENSG00000205413 SAMD9 Q5K651

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
IMPLITAPIDEMTTPSmall moleculeINHIBITORMicrosomal triglyceride transfer protein inhibitor20
LOMITAPIDE MESYLATEMTTPSmall moleculeINHIBITORMicrosomal triglyceride transfer protein inhibitor40
LOMITAPIDEMTTPSmall moleculeINHIBITORMicrosomal triglyceride transfer protein inhibitor40
SLX-4090MTTPSmall moleculeINHIBITORMicrosomal triglyceride transfer protein inhibitor20
DIQUAFOSOLP2RY2Small moleculeAGONISTPyrimidinergic receptor P2Y6 agonist30
DIQUAFOSOL TETRASODIUMP2RY2Small moleculeAGONISTPyrimidinergic receptor P2Y6 agonist30

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-1927

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-09798OR51A2up-regulatesHBP1activatesR-1927121Drugs (6)
CMF-15912TUBBP5up-regulatesHBP1activatesR-1927122Drugs (6)
CMF-33477TCR_SIGNALING_IN_NAIVE_CD4+_T_CELLSup-regulatesHBP1activatesR-1927127Drugs (6)